tiprankstipranks
Advertisement
Advertisement
INVA Earnings this Week: How Will it Perform?
PremiumPre-EarningsINVA Earnings this Week: How Will it Perform?
1M ago
Innoviva: Buy Rating Reiterated as LYNX Platform Strengths Support Unchanged $42 Price Target
Premium
Ratings
Innoviva: Buy Rating Reiterated as LYNX Platform Strengths Support Unchanged $42 Price Target
3M ago
Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged
Premium
Ratings
Innoviva Maintained at Buy as Analyst Highlights Nortiva LYNX Platform Upside, Keeps $46 Price Target Unchanged
3M ago
Innoviva reports Q4 EPS $1.94 vs. 26c last year
PremiumThe FlyInnoviva reports Q4 EPS $1.94 vs. 26c last year
6M ago
Innoviva initiated with a Buy at BTIG
Premium
The Fly
Innoviva initiated with a Buy at BTIG
7M ago
Innoviva: Durable Royalty Backbone and High-Growth Hospital Portfolio Underpin Buy Rating and $35 Target
Premium
Ratings
Innoviva: Durable Royalty Backbone and High-Growth Hospital Portfolio Underpin Buy Rating and $35 Target
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100